Floatz logo

Rencofilstat

NASH With Fibrosis

Hepion Pharmaceuticals, Inc.Small moleculePhase 2Active
BB
69/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
54/ 100
Competitive Position
95/ 100

Competitive context

3 Active assets in the NASH With Fibrosis cohort.

Asset / SponsorPhaseRating
Dasatinib
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Phase 1/2CCC
FLAVONE, 3,3',4',5,7-PENTAHYDROXY-
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Phase 1/2CCC
[14c]-rencofilstat
Hepion Pharmaceuticals, Inc.
Early Phase 1CC

Same molecule, other indications

Rencofilstat is also rated in:

metabolic dysfunction-associated steatohepatitisDormant
B
Indicative ·
62 / 100
View asset →
fibrotic liver diseaseDormant
B
Indicative ·
57 / 100
View asset →
metabolic dysfunction-associated steatotic liver diseaseDormant
B
Indicative ·
57 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →